Historical Stock Price
| Home |
| Free Dividend Report |
| ABBV Dividend History |
| ABBV Historical Stock Prices |
| Preferred Stock Newsletter |
| ABBV Options Chain |
| ABBV Message Board |
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on August 08, 2022, ABBV opened at $138.04, traded as high as $140.80 and as low as $137.77, and closed at $140.34. Trading volume was a total of 4.85M shares. On August 09, 2022, ABBV opened at $140.68, traded as high as $142.24 and as low as $139.88, and closed at $140.25. Trading volume was a total of 3.82M shares. On August 10, 2022, ABBV opened at $140.91, traded as high as $141.06 and as low as $139.00, and closed at $140.94. Trading volume was a total of 4.08M shares. On August 11, 2022, ABBV opened at $140.23, traded as high as $142.87 and as low as $139.66, and closed at $142.08. Trading volume was a total of 5.97M shares. On August 12, 2022, ABBV opened at $141.89, traded as high as $143.09 and as low as $140.27, and closed at $142.60. Trading volume was a total of 5.21M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 With Dividends Reinvested |
|||
| Start date: | 01/03/2013 | ||
| End date: | 08/12/2022 | ||
| Start price/share: | $34.83 | ||
| End price/share: | $142.60 | ||
| Starting shares: | 287.11 | ||
| Ending shares: | 428.42 | ||
| Dividends reinvested/share: | $32.14 | ||
| Total return: | 510.93% | ||
| Average Annual Total Return: | 20.73% | ||
| Starting investment: | $10,000.00 | ||
| Ending investment: | $61,108.04 | ||
| Years: | 9.61 | ||
|
Growth of $10,000.00 Without Dividends Reinvested |
|||
| Start date: | 01/03/2013 | ||
| End date: | 08/12/2022 | ||
| Start price/share: | $34.83 | ||
| End price/share: | $142.60 | ||
| Dividends collected/share: | $32.14 | ||
| Total return: | 401.69% | ||
| Average Annual Total Return: | 18.28% | ||
| Starting investment: | $10,000.00 | ||
| Ending investment: | $50,181.99 | ||
| Years: | 9.61 | ||
 | |||||
| ABBV Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 08/08/2022 | $138.04 | $140.80 | $137.77 | $140.34 | 4.85M |
| 08/09/2022 | $140.68 | $142.24 | $139.88 | $140.25 | 3.82M |
| 08/10/2022 | $140.91 | $141.06 | $139.00 | $140.94 | 4.08M |
| 08/11/2022 | $140.23 | $142.87 | $139.66 | $142.08 | 5.97M |
| 08/12/2022 | $141.89 | $143.09 | $140.27 | $142.60 | 5.21M |
|
| About AbbVie |
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. |
| ABBV Historical Closing Prices | |
| Date | Close |
| 08/08/2022 | $140.34 |
| 08/09/2022 | $140.25 |
| 08/10/2022 | $140.94 |
| 08/11/2022 | $142.08 |
| 08/12/2022 | $142.60 |
| Healthcare Historical Prices |
| ABBV is categorized under the Healthcare sector; below are some other companies in the same sector:
ABC Historical Stock Prices Also explore: ABBV shares outstanding history
|
Free ABBV Email Alerts:
